1998 - 2000 The University of Houston, Main Campus, B.S. in Biology
2002 - 2006 The Universtiy of Texas Medical School at Houston, MD
2006 - June 2010 The University of Texas Medical School at Houston, Resident in Anatomical and Clinical Pathology
July 2010 - July 2011 University of Texas MD-Anderson, Fellow in Surgical Pathology
July 2011 - July 2012 University of Texas MD-Anderson, Combined Cancer Biomarker with Gastrointestinal subspecialty fellowship
2012 Assistant Professor of Pathology, University of Vermont College of Medicine
2012 Ordóñez NG, Shen SS, Zenali M, Deavers MT. Melan-A is not a marker of mesothelioma. Appl Immunohistochem Mol Morphol. 2012 Jul. 2010 Zenali M J, Tan D, Li W, Dhingra S, Brown RE. Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma. Ann Clin Lab Sci. 2010 Spring; 40(2):126-34.
2010 Dhingra S, Tan D, Li W, Zenali M J, Brown RE. Cell Cycle Biology of Fibrolamellar Hepatocellular Carcinoma. Int J Clin Exp Pathol. 2010 Nov 2;3(8):792-7.
2009 Zenali M J, Zhang PL, Brown RE, Morphoproteomic Confirmation of Constitutively Activated mTOR, ERK, and NF-kappaB Pathways in Ewing Family of Tumors, Ann Clin Lab Sci. 2009 Spring; 39(2): 160-6. 2009 Burrus, MT, Ramos Y, Zenali M J. An infective cancer – a rare disease with a rarer transformation. UT-Houston Journal of Internal Medicine. Vol 1 (3). Dec 23, 2009
For a complete list of Maryam Zenali's publications, please visit PubMed.